Short Squeeze - CMMB Long

Chemomab Therapeutics Ltd.NASDAQ

Description

⋅ May 26, 2021 3:26 PM

Idea for Chemomab Therapeutics Ltd.:
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.

- Bottom of Risk Range:

- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.

Bought the shares $16.69
Expect share dilution $40-$50

GLHF
- DPT

Order cancelled

⋅ Jun 1, 2021 3:31 PM

Comments

brandonlee485

⋅ Jun 11, 2021 3:41 AM

You closed your trade too early lol.

brandonlee485

⋅ May 31, 2021 7:45 AM

Have you been able to find a utilization rate for this stock?

Wilson5s

⋅ May 27, 2021 11:12 PM

when do you think this bad boy can squueze?